Researchers from the College of Medicine at the University of Florida have found a relationship between drugs used to lower blood pressure, and a reduced risk of diabetes amongst Hispanic patients.
Hispanic patients, according to the researchers, can benefit from a drug strategy including beta-blockers, diuretics, calcium antagonists and ACE inhibitors. This approach has the result of lowering blood pressure amongst Hispanics, as well as reducing their risk of developing type 2 diabetes.
The results from the study are reported in the May issue of the American Heart Journal, and will be well received by the Hispanic community. Diabetes is rife amongst Hispanic people: they are one of the ethnic groups more prone to developing the disease.
One researcher involved in the study reportedly said that: “We can successfully lower blood pressure in Hispanic patients with heart disease with medications that include beta-blockers like atenolol or calcium antagonists like verapamil plus the ACE inhibitor trandolapril, especially when compared with non-Hispanic patients. Lower blood pressure translated into fewer heart attacks and fewer strokes, which is very important for reducing cardiovascular risk in both Hispanics and non-Hispanics. The use of trandolapril and verapamil, however, also significantly reduced the risk of developing diabetes in Hispanic patients.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…